Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-25-105153

Options or other derivatives

  • Chief Financial Officer acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fuhrman Alan Chief Financial Officer 2025-08-07 Grant or award · Stock Option (Right to Buy) +170,000 170,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…